VATICAN CITY (EWTN News/CNA)— The Vatican has signed its first-ever commercial agreement with an outside company. The contract with U.S.-based bio-pharmaceutical firm NeoStem will advance ethical research into stem cells.
“We would like to create a hotspot for scientists, benefactors, academics (and) Church leaders that will now join this group and would work together for the benefit of humanity,” Father Tomaz Trafny of the Vatican’s Council for Culture told EWTN News June 16.
The deal was announced before the global media in Rome.
“We are a public company pioneering new medical research with adult stem cells,” explained Dr. Robin Smith, the CEO of NeoStem, which is based in New York....READ MORE